
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1072018-68-8 |
| Catalog No. | 2A-0101424 |
| Chinese Name | 3,5-二氯-N-[[4-氟-1-[[(4S)-四氢-2,2-二甲基-2H-吡喃-4-基]甲基]-4-哌啶]甲基]苯甲酰胺 |
| Synonyms | References |
| Molecular Formula | C21H29Cl2FN2O2 |
| Molecular Weight | 431.37200 |
| Purity | 96+ |
| Application | T-type calcium channel inhibitor is a potent T-type calcium channel inhibitor. T-type calcium channel inhibitors can penetrate the central nervous system well, block the intrinsic T-type current of ne |
| EINECS | 0 |
| HTC | 2934999090 |
| UN(IATA) | 0 |
| SMILES | CC1(C)CC(CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1 |
| InChI Key | DKNDOKIVCXTFHJ-HNNXBMFYSA-N |
| MSDS | msds/101424_1_1072018_68_8.pdf |
| Use of | Properties Name 3,5-dichloro-N-[[1-[[(4S)-2,2-dimethyloxan-4-yl]methyl]-4-fluoropiperidin-4-yl]methyl]benzamide Synonym More Synonyms Biological Activity Related Catalog Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel Research Areas >> Neurological Disease References [1]. Chemin J, et al. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene. Brain. 2018;141(7):1998-2013. Chemical & Physical Properties Exact Mass 430.15900 PSA 41.57000 LogP 5.06130 InChIKey DKNDOKIVCXTFHJ-HNNXBMFYSA-N Safety Information HS Code 2934999090 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-2-PHENYL-2-(PHENYLAMINO)ETHANOL | 135285-98-2 | 2A-0101406 |
| (S)-2-PHENYLDIHYDRO-2H-PYRAN-4(3H)-ONE | 82110-28-9 | 2A-0101407 |
| (S)-2-PHENYLPROPANAMIDE | 13490-74-9 | 2A-0101410 |
| (S)-3,3,3-TRIFLUORO-2-HYDROXYPROPANOIC ACID | 125995-00-8 | 2A-0101420 |
| (S)-3,3,3-TRIFLUORO-2-METHOXY-2-PHENYLPROPANOYL CHLORIDE | 20445-33-4 | 2A-0101422 |
| (S)-3,5-DICHLORO-N-((1-ETHYLPYRROLIDIN-2-YL)METHYL)-2,6-DIHYDROXYBENZAMIDE | 119670-11-0 | 2A-0101425 |
| (S)-3,5-DICHLORO-N-((1-ETHYLPYRROLIDIN-2-YL)METHYL)-2,6-DIHYDROXYBENZAMIDE HYDROBROMIDE | 113310-88-6 | 2A-0101426 |
| (S)-3,7-DIHYDROXY-2,3-DIHYDROPYRROLO[2,1-B]QUINAZOLIN-9(1H)-ONE | 84847-50-7 | 2A-0101428 |
| (S)-3,9-DIMETHOXY-6,8,13,13A-TETRAHYDRO-5H-ISOQUINOLINO[3,2-A]ISOQUINOLINE-2,10-DIOL | 16562-13-3 | 2A-0101430 |
| (S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(((BENZYLOXY)METHYL)AMINO)PROPANOIC ACID | 142855-80-9 | 2A-0101431 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA